Summary
A comprehensive episode on vitamin C science. Covers oral bioavailability vs intravenous, immune cell function, effects on common cold and viral infections, lung function benefits, sepsis and pneumonia applications, inflammation, IV vitamin C in cancer treatment, the debate about whether vitamin C blunts exercise adaptation, vitamin C's role in fatty acid oxidation and obesity, brain effects on memory and cognition, cardiovascular health, and safety considerations including kidney stone risk.
Key Points
- Oral vitamin C has limited bioavailability compared to intravenous
- Vitamin C improves lung function and supports immunity against viral infections
- The debate continues on whether vitamin C supplementation blunts exercise adaptations
- IV vitamin C is being studied as adjunct therapy for certain cancers and infections
- Vitamin C plays a role in fatty acid oxidation with relevance to obesity
- High-dose vitamin C may increase kidney stone risk in susceptible individuals
Key Moments
IV vitamin C as a cancer therapeutic strategy
IV vitamin C achieves plasma levels far beyond oral dosing, showing promise as a therapeutic strategy against cancer and serious illness.
"Although it's not the typical means of getting this essential vitamin, it offers promise as a therapeutic strategy against cancer and some other serious health concerns."
Immune cells concentrate vitamin C 50-100x plasma
Neutrophils hold 50-100x more vitamin C than plasma, serving as a potent antioxidant shield during immune response.
"Vitamin C is highly concentrated in immune cells, with neutrophils and leukocytes having 50 to 100 times higher vitamin C concentrations than plasma."
